2019 CPT Code Changes

Effective January 1, 2019, there will be CPT code changes for pathology and laboratory testing services provided by PathGroup.

For more information, CLICK HERE.

 

 

Christopher Coldren PhD Co-Authors AMP Journal of Molecular Diagnostic Article

Brentwood, TN – (Wednesday, March 7, 2018) – PathGroup, a premier provider of anatomic, clinical and molecular pathology laboratory services, is pleased to announce that Christopher Coldren, PhD has co-authored an evidence based guideline published in the Journal of Molecular Diagnostics (Nov. 2017) entitled “Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines.”

To read the full release, CLICK HERE

TEST UPDATE: Herpes Simplex Virus 1 and 2

Effective March 5, 2018, PathGroup has switched Herpes Simplex Virus 1 and 2 (HSV 1 & 2) detection from a laboratory developed Polymerase Chain Reaction (PCR) methodology to the FDA-approved Aptima HSV 1 & 2 Assay.

For more information, CLICK HERE

TEST UPDATE: Mycoplasma genitalium

Effective today, February 12, 2018, PathGroup offers testing for Mycoplasma genitalium, intended for use as an aid in the diagnosis of M. genitalium urogenital infections in male and female patients.

For more information, CLICK HERE

TEST UPDATE – Glucose

Effective December 1, 2017, PathGroup Labs will adjust the glucose reference range for GLUCOSE (Test Code: GLU) to conform to the recommendations of the American Diabetes Association for the classification of prediabetes.

For more information, CLICK HERE

UPDATE: Non-Covered ICD-10 Codes

On November 1, 2017, a PathConnect software update will take place that will further restrict entry of any non-covered ICD-10 diagnosis codes for Medicare patients.

For more information, CLICK HERE